Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Офтальмология / Английские материалы / Moorfields Manual of Ophthalmology_Jackson_2007

.pdf
Скачиваний:
0
Добавлен:
28.03.2026
Размер:
32.21 Mб
Скачать

1.Intravitreal biopsy and antibodies as soon as possible, preferably at first hospital contact. For technique, see Box 8.1.

2.Moxifloxacin 400mg od PO for 10 days.

3.Gutte dexamethasone 0.1% preservative free hourly, steroid ointment nocte, chloramphenicol 0.5% qds, cyclopentolate 1% tds.

4.Analgesia

5.Anterior chamber tissue plasminogen activator (12.5mcg in 0.1ml) if there is severe fibrinous response.

6.Subconjunctival 0.3 ml Mydricaine II if poor pupil dilation.

7.Review Gram/Giemsa stain the same day.

8.After 24 hours start enteric coated prednisolone 1 mg/kg/day with ranitidine 150 mg bd. Steroids are contrindicated in fungal endophthalmitis so check Gram and Giemsa stain. Candida spp are Gram positive but other fungi are only detected with Giesma stain.

Review 48 hours after intravitreal injection

Better (improved red reflex

or hypopyon)

Review in 1–2 weeks

Same or worse

1.Review sensitivities and discuss with microbiologist.

2.Repeat intravitreal antibodies.

Review in 48 hours

 

Better

Same or worse

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Review in 1–2 weeks

 

 

Consider vitrectomy

 

 

 

 

 

 

 

 

 

 

Fig. 8.22: Treatment of acute postoperative endophthalmitis.

Treatment

For children, discuss the drug dose and selection with a pharmacist. For adults, see Fig. 8.22.

Moxifloxacin may have an antibiofilm effect on coagulasenegative staphylococci and a better spectrum of activity than ciprofloxacin, but use ciprofloxacin 750 mg b.d. 10 days if not available.

Consider periocular steroids if systemic steroids are contraindicated.

Chronic endophthalmitis usually responds to treatment, but some cases recur when treatment is stopped, as organisms

UVEITIS 8 Chapter

may be sequestered behind the lens. Re-treat with intravitreal

 

and systemic antibiotics but if inflammation recurs again then

 

arrange IOL and total capsule removal. Send samples at each

383

Endophthalmitis

stage for microbiology and histopathology. Avoid systemic steroids that may mask ongoing inflammation.

The Endophthalmitis Vitrectomy Study (EVS)1 was a large randomized, controlled trial that suggested early vitrectomy with intravitreal antibiotics may improve the final VA for patients with PL vision. Recent local experience suggests that early vitrectomy results in a worse prognosis for those with PL vision but many other centres follow the EVS recommendations.

Some reports advocate intravitreal ceftazidime 2 mg in 0.1 mL instead of amikacin for Gram-negative cover, because of the risk of aminoglycoside retinal toxicity. Avoid combining vancomycin and ceftazidime in the same syringe.

Some reports advocate intravitreal dexamethasone 0.4 mg but the evidence is not clear.

Follow-up Manage patients as day-cases if they can cope; otherwise admit. If admitted, consider discharge when there is clinical improvement, typically after 48 hours, and then review within 2 weeks. Follow up all patients for 3–6 months, as they may require additional procedures, e.g. vitrectomy for vitreous debris. Final VA is <6/60 in 22–77%. Patients with an acute presentation, good presenting VA, and negative cultures tend to have a better prognosis.

Endogenous Endophthalmitis

Endogenous endophthalmitis is haematogenous spread of infection to the eye. Commonest in the elderly, debilitated, diabetics, those with indwelling foreign bodies (urinary or i.v. catheters, prosthetic heart valves), immunosuppressed (iatrogenic or disease) and i.v. drug users. Patients may or may not be acutely ill and can present with either a fulminating or low-grade endophthalmitis. Manage in combination with a physician to identify the source, predisposing disease, and treatment options. Request blood cultures.

Endogenous bacterial endophthalmitis : If the organism is not known obtain aqueous and vitreous taps (Box 8.1)and give oral and intravitreal antibiotics as described for exogenous infection.

Endogenous fungal endophthalmitis : The majority are diagnosed on clinical grounds, most typically in i.v. drug users or following a septic or other hospital episode involving intravenous cannulation, or broad-spectrum antibiotics.

 

Collections of cells may be seen in the choroid, retina, or

 

vitreous. These may form ‘puff-balls’ (Candida spp.) or hyphae

 

(Aspergillus spp.). Fungal endophthalmitis is uncommon after

 

intraocular surgery or secondary to penetrating injury. Candida

 

384

species are by far the most common (Fig. 8.23). Aspergillus

 

 

Box 8.1: Aqueous and vitreous tap and intravitreal antibiotic injection

1.Contact the microbiology department to ensure Gram staining is done the same day.

2.Instil G. proxymetacaine then tetracaine (amethocaine), then povidone-iodine 5% into the conjunctival sac and on the lid margins. Allow dwell time for bacterial/fungal killing.

3.Administer subconjunctival or more usually peribulbar anaesthesia (lidocaine 2%).

4.Prepare then draw up the required concentration of antibiotics, combined into a 1 mL syringe (change the needle, as this gets blunt going through the rubber bungs):

a.Vancomycin : 2.0 mg in 0.1 mL.

b.Amikacin : 0.4 mg in 0.1 mL (beware dilution errors).

c.Amphotericin B : 5–10 mcg in 0.1 mL only if fungi are suspected.

5.Scrub and don gloves. A drape and mask are not required. Insert the lid speculum but do not further manipulate the lashes. Wash away excess povidone-iodine with saline.

6.Aqueous sampling (may be done with patient at the slit lamp or

lying down). Using a 1 mL syringe (not an insulin syringe) with an orange 25-gauge needle, aspirate 0.1–0.2 mL of aqueous via a limbal paracentesis. A larger needle may be used if a lot of pus is present. Place the needle into the sheath left resting on a flat surface, without touching the tip of the needle (be mindful of needle-stick). Label and leave to one side.

7.Vitreous sampling (do in a sterile environment with the patient lying flat). Use a 5 mL syringe and blue 23-gauge needle and insert 4 mm (phakic) or 3.5 mm (pseudophakic/aphakic eyes) behind the limbus into the midvitreous cavity. Aspirate 0.2– 0.4 mL. If the tap is dry, carefully move the needle within the vitreous cavity. If still dry, try a larger 21-gauge needle. Place

the sheath on the needle as above. Label and leave to one side.

8.Inject the 0.2 mL of combined intravitreal antibiotics in the 1 mL syringe in a sterile manner and through the same area as the vitreous sampling. As the eye can be very soft, counter pressure helps get the needle through the sclera.

(Continued on next page)

UVEITIS 8 Chapter

385

Endophthalmitis

Box 8.1: Aqueous and vitreous tap and intravitreal antibiotic injection—cont’d

9.Plate out immediately, as per local protocol, for example:

a.Blood agar: place one drop from the syringe on an eccentric one-third of the plate and then streak with a loupe. Do not cut into the agar, as the organisms will not grow. Use a separate blood agar plate for aqueous and vitreous. Close with tape, and label.

b.Robertson’s cooked meat broth and brain heart infusion: put one drop in each bottle (avoid touching the rim). Close, mix, and label.

10.Send specimens immediately to the microbiology department for Gram (± Giemsa) stain, and then culture. If the laboratory is closed, incubate the plates and transfer at the first opportunity, but this may reduce the yield so avoid if possible.

Fig. 8.23: Candida endophthalmitis extending from the retina into the vitreous.

 

and others are rare. Treatment is determined by the site of the

 

lesion. Treat lesions confined to the choroid (outside the blood–

 

retinal barrier) with intravenous amphotericin B. Lesions

 

extending into the vitreous require planned vitrectomy within 2

 

days (so no need to take samples in casualty) with intraocular

 

amphotericin B (10 μg), and fluconazole starting with 400 mg

 

loading dose p.o. then 200 mg b.d. p.o. for 6 weeks (penetrates

 

well into the eye). Alternatively, use oral voriconazole. For flat

 

386

lesions in the retina give a trial of oral fluconazole.

 

 

Optometry and General

Practice Guidelines

General Comments

Accurate diagnosis and assessment of patients with uveitis requires slit lamp examination. This is not usually available in general practice and topical steroids should not be initiated owing to their potential side effects including raised intraocular pressure, cataract, and exacerbation of dendritic corneal ulcers. All suspected intraocular inflammation should therefore be referred within 24 hours to an ophthalmologist.

Acute anterior uveitis accounts for 90% of all intraocular inflammation presenting to general practitioners but it accounts for a minority of patients with red eye.

General Practice

Photophobia and pain are the predominant complaints in patients with uveitis, with conjunctival injection centred primarily around the cornea (circumcorneal injection). It is usually possible to distinguish anterior uveitis from conjunctivitis from the history (p. 142).

Posterior uveitis is more difficult to diagnose from the history and is reliant upon proficient dilated fundoscopy. Symptoms of acute onset of floaters, with or without blurred vision, are far more likely to be related to posterior vitreous detachment than inflammation, but in either event urgent referral is required.

Optometrists

Optometrists who suspect anterior uveitis should take a careful history and look for anterior chamber cells. These are best seen against a dilated pupil, using a thin, maximally illuminated slit beam passed at 45º through the anterior chamber. Inflammatory cells can be seen to percolate upward in the back of the anterior chamber, and downwards immediately behind the cornea (see Fig. 8.1). Look for anterior vitreous activity using the same slit beam focused behind the lens. For patients with suspected posterior uveitis, look for vitreous haze, macular oedema, and perivascular infiltrates. Pars planitis may be difficult to detect without indentation. Any anterior or posterior segment inflammation requires same-day review by an ophthalmologist.

References

UVEITIS 8 Chapter

1. No authors listed. The Endophthalmitis Vitrectomy Study. Arch

 

Ophthalmol 1995; 113:1479–1496.

387

Chapter 9

OCULAR ONCOLOGY

Conjunctival Tumours

Symptoms Non-specific symptoms include ocular pain, redness and discharge. Vision loss may occur from tumour growth covering the cornea or inducing astigmatism.

History and examination Ask about sun exposure. Perform detailed anterior segment slit lamp examination including the caruncle and conjunctival fornices by everting the upper eyelid. Palpate for enlarged preauricular or submandibular lymph nodes.

Differential diagnosis

The commoner lesions and their main features include:

Nonpigmented tumours:

1.Papilloma (Fig. 9.1): a. Benign.

b. Pink fibrovascular fronds (pedunculated or flat).

c.Viral aetiology.

d.Symptomatic when large.

e.Treat by delicate surgical excision, cryotherapy and topical therapy (interferon or mitomycin C).

2.Conjunctival intraepithelial neoplasia (CIN) (Fig. 9.2):

a.Benign (pre-malignant).

b. Histologic grades (I–III) are based on the depth of conjunctival epithelial involvement.

c.Fleshy, thickened, vascularized lesion located at the interpalpebral limbus with occasional corneal extension.

d. Treat by excisional biopsy. Adjuvant cryotherapy and topical therapy (interferon or mitomycin C) may be used.

388

ONCOLOGY OCULAR 9 Chapter

Fig. 9.1: Conjunctival papilloma.

Fig. 9.2: Conjunctival intraepithelial neoplasia.

3.Squamous cell carcinoma (SCC) (Fig. 9.3): a. Malignant.

b.

Fleshy, pink, elevated masses with feeder vessels; can

 

 

extend widely across the conjunctiva and invade deep

 

 

into the orbit.

 

c.

Manage by excision with adjuvant cryotherapy, topical

 

 

 

mitomycin C, or beta radiotherapy. Extensive local and

389

 

 

 

Conjunctival tumours

Fig. 9.3: Invasive squamous cell carcinoma.

Fig. 9.4: Conjunctival naevus.

regional recurrence may require orbital exenteration with external beam radiotherapy.

Pigmented tumours: 1. Naevus (Fig. 9.4):

 

a.

Benign.

 

b. Circumscribed, light brown, flat lesion in the

 

 

interpalpebral zone and often with epithelial

 

 

downgrowth cysts.

 

c. Manage with photodocumentation and routine yearly

 

390

 

observation if stable. Growing lesions and those that

 

 

 

Fig. 9.5: Primary acquired melanosis.

develop prominent feeder vessels can be biopsied to rule out malignant melanoma.

2.Primary acquired melanosis (PAM) (Fig. 9.5): a. Benign (premalignant).

b. Diffuse, patchy foci of increased conjunctival pigmentation. Sometimes extends to the eyelid skin and is occasionally nonpigmented. Acquired in middleage and found in light-skinned patients.

c.Manage by observation every 6 months with or without multiple incisional biopsies.

d. Confirmed areas of PAM with atypia may be treated with cryotherapy although it is not certain whether freezing reduces a 50% risk of developing conjunctival melanoma.

e.Dark-skinned patients may have diffuse racial pigmentation seen near the limbus, which is generally benign and does not require treatment or follow-up.

3.Malignant melanoma (MM) (Fig. 9.6): a. Malignant.

b. May arise from a naevus, PAM, or de novo.

c.Typically, darkly pigmented and focal, but variations include nonpigmented and diffuse forms. Feeder

ONCOLOGY OCULAR 9 Chapter

391

Conjunctival tumours

Fig. 9.6: Hyperpigmented conjunctival melanoma with sentinel vessels.

vessels may be present. Tumours arising in PAM may be multifocal and the eyelid skin may be affected.

d. Manage by wide, en bloc excision with lamellar dissection of the cornea and sclera at the cornoscleral limbus. Adjuvant cryotherapy or beta plaque radiotherapy may be applied to the tumour bed if there is doubt about the completeness of excision.

e.Careful follow-up is needed to identify new tumours arising in PAM and recurrences.

f.Extensive or recurrent lesions may require orbital exenteration.

g. Spread may occur to regional lymph nodes and is best managed by a combination of surgical excision of affected nodes and external beam radiotherapy. Metastatic disease can occur and may be fatal.

4.Ocular melanocytosis (Fig. 9.7):

a. Unilateral, congenital hyperpigmentation of the uveal tract extending to the episclera and presenting with increased iris pigmentation on the affected side and slate-grey discoloration of the sclera.

 

b. Termed oculodermal melanocytosis (naevus of Ota )

 

392

if associated with ipsilateral periocular blue-grey